MEDICARE COVERAGE OF INVESTIGATIONAL DEVICES SUPPORTED BY "INCREMENTAL NATURE" OF DEVELOPMENT, HIMA TESTIFIES; HCFA TO ISSUE POLICY ON OFF-LABEL PAYMENT
This article was originally published in The Gray Sheet
Executive Summary
The "incremental nature" of device development argues for Medicare coverage of investigational devices, Thomas Long, vice president of payment and policy at the Health Industry Manufacturers Association asserted at a Sept. 12 meeting of the Health Care Financing Administration's Practicing Physicians Advisory Council.